Looks like you’re on the UK site. Choose another location to see content specific to your location
Antibiotics and Antivirals
Antibiotics, vital in pharmaceuticals, combat bacterial infections by either killing bacteria or impeding their growth. Pharmaceutical companies invest in research to discover and develop these drugs, categorized into classes like penicillins and tetracyclines. Antivirals, another pharmaceutical cornerstone, target viral infections by inhibiting viral replication. Developed through focused research, antivirals vary in classes such as nucleoside analogs and protease inhibitors
In the pharmaceutical industry, both antibiotics and antivirals undergo rigorous testing in preclinical and clinical trials to demonstrate safety and efficacy before receiving regulatory approval. The ongoing challenge for pharmaceutical companies is to address emerging infectious diseases, combat resistance, and ensure a continuous supply of effective antimicrobial agents.